Boothbay Fund Management, LLC Immunovant, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$31.31 - $44.19 $2.51 Million - $3.54 Million
-80,100 Reduced 69.35%
35,400 $1.49 Million
Q3 2023

Nov 14, 2023
BUY
$18.55 - $39.96 $1.86 Million - $4.01 Million
100,300 Added 659.87%
115,500 $4.43 Million
Q2 2023

Aug 14, 2023
BUY
$14.2 - $23.75 $215,840 - $361,000
15,200 New
15,200 $288,000
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $249,100 - $446,525
26,500 New
26,500 $280,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email